T
Thomas Pezawas
Researcher at Medical University of Vienna
Publications - 35
Citations - 510
Thomas Pezawas is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Implantable cardioverter-defibrillator & Sudden cardiac death. The author has an hindex of 12, co-authored 35 publications receiving 434 citations. Previous affiliations of Thomas Pezawas include University of Vienna.
Papers
More filters
Journal ArticleDOI
Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Clinical presentation, risk stratification and results of long-term follow-up
Thomas Pezawas,Guenter Stix,Johannes Kastner,Barbara Schneider,Michael Wolzt,Herwig Schmidinger +5 more
TL;DR: In ARVD/C the tachycardia cycle length of clinical VT, PVS-induced VT and follow-up VT correlate well implicating that a PVS -guided approach does not provide additional information.
Journal ArticleDOI
Implantable loop recorder in unexplained syncope: classification, mechanism, transient loss of consciousness and role of major depressive disorder in patients with and without structural heart disease
Thomas Pezawas,Günter Stix,Johannes Kastner,Barbara Schneider,Michael Wolzt,Herwig Schmidinger +5 more
TL;DR: The presence of SHD has little predictive value for the occurrence or type of arrhythmia in patients with unexplained syncope, and the ILR leads to specific treatment in half of all patients.
Journal ArticleDOI
Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantable cardioverter defibrillator therapy
Thomas Pezawas,Günter Stix,Johannes Kastner,Michael Wolzt,Christian Mayer,D. Moertl,Herwig Schmidinger +6 more
TL;DR: In this paper, electrophysiologically guided implantable cardioverter defibrillator (ICD) therapy was evaluated in patients with syncope, structural heart disease and no documented sustained ventricular tachycardia (sVT).
Journal ArticleDOI
Electromagnetic interference by transcutaneous neuromuscular electrical stimulation in patients with bipolar sensing implantable cardioverter defibrillators: a pilot safety study.
Richard Crevenna,Günter Stix,Johannes Pleiner,Thomas Pezawas,Herwig Schmidinger,Michael Quittan,Michael Wolzt +6 more
TL;DR: Electromagnetic interference by Transcutaneous Neuromuscular Electrical Stimulation in Patients with Bipolar Sensing Implantable Cardioverter Defibrillators and the safety of peripheral NMES has to be individually tested as EMI can also occur in ICD patients with bipolar sensing.
Journal ArticleDOI
Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies
Oliver Findling,Larissa Hauer,Thomas Pezawas,Paulus S. Rommer,Walter Struhal,Johann Sellner,Johann Sellner +6 more
TL;DR: Although a substantial evidence base suggests that assessing CAD in people with MS may be important, standardised methods to evaluate CAD in these patients have not yet been established, and no studies have yet looked at whether treating CAD can reduce the burden of MS symptoms, disease activity or the rate of progression.